Rocky Ganske

Bayer Corp. manufactures and markets pharmaceutical, healthcare, nutrition and materials products. The firm offers consumer care, diagnostics, diabetes and animal health products. It also provides material science products, which include coating, adhesive and sealant raw materials polycarbonates polyurethanes and thermoplastic polyurethane elastomers. The company was founded in 1973 and is based in Whippany, NJ.

Protedyne Corp. provides industrial-quality automation and data management services. It offers genome-based drug discovery equipment. The firm also provides automation systems that combine laboratory robotic hardware with a software infrastructure to ensure data management and process tracking. The company was founded by Stan Klein in June 2000 and is headquartered in Windsor, CT.

ActivBiotics, Inc. discovers and develops pharmaceutical drugs. It provides discovery, development, and commercialization of therapies for the treatment of vascular disease, inflammation, and other high-value chronic and infectious diseases. The company was founded in 1996 and is headquartered in Lexington, MA.

Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA.

Siemens Canada Ltd. manufactures communication products, medical equipment and industrial products. It provides products for the health care, information and communications, energy and power, automation, transportation and building technologies. The company was founded in 1874 and is headquartered in Oakville, Canada.

Biometric Imaging, Inc. manufactures cellular analysis instruments. It offers services to clinics, hospitals, blood banks, and cancer management centers for disease management and therapy monitoring. The company was founded by Bala S. Manian in 1992 and is headquartered in Mountain View, CA.

CDP Capital Private Equity (CDPQ) is a private equity subsidiary of The Caisse de dépôt et placement du Québec founded in 1995. The firm is headquartered in Montréal with additional office in London.

Part of Harvard Bioscience, Inc., FKAUBI, Inc. is a company that specializes in Union Biometrica publications and UnionBio Applications. The company is based in Somerville, MA. The company offers an introduction to Large Object Flow Cytometry. FKAUBI was acquired by Harvard Bioscience, Inc. on May 31, 2001 for $13.37 million.

BD Biosciences, Systems & Reagents, Inc. provides tools and solutions to research and clinical laboratories in basic research, drug discovery, development, biopharmaceutical production and disease management. The company was founded on May 9, 1991 and is headquartered in San Jose, CA.

Axela, Inc. develops biosensor technology. It offers next generation, commercial stage, multiplex tools that provide enhanced analysis of proteins, DNA and RNA. The firm’s products include Ziplex System, autograph, metabolic, colon and breast cancer, inflammation Xpress chips, diffractive optics technology and sensors, dotLab mX System and dot-Avidin, Ready and Covalent products. The company was founded by M. Cynthia Goh, Richard Loo, B. Jane Goh and Richard McAloney in 2001 and is headquartered in Toronto, Canada.

HX Diagnostics, Inc. provides diagnostic services for infectious diseases. It develops and commercializes seasonal and pandemic influenza assays that allow clinicians to make assessments of their patient's health status. The company was founded in 2006 and is headquartered in San Diego, CA.

Interface Biologics, Inc. operates as a commercial stage privately held company that develops transformative biomedical polymer technologies to improve the safety and effectiveness of medical devices. It provides technologies to medical device manufacturers and drug companies. The company was founded by Paul J. Santerre in December 2001 and is headquartered in Toronto, Canada.

Cephos Corp. develops biotechnology products. The private company is based in Pepperell, MA.

Abbott Diagnostics, Inc. develops, manufactures and sells medical diagnostic instrument, test and automation products. The company is headquartered in Santa Clara, CA.

Pharmascience, Inc. manufactures and distributes generic and drug products. It offers liquids, tablets, capsules, suppositories, powders, and ophthalmic. The company was founded by Morris Goodman and Ted S. Wise in 1983 and is headquartered in Montr?al, Canada.

Verde Ventures (Verde) is a venture capital subsidiary of Conservation International Foundation founded in 1998. The firm is headquartered in Arlington, Virginia.

Ontario Institute for Cancer Research provides research on the prevention, early detection, diagnosis, and treatment of cancer. It offers Innovation programs, like cancer stem cell, innovation in target validation, and smarter imaging, Technology programs, like drug discovery, genome technologies, informatics and bio-computing, imaging translation, and tranformative pathology, and Translation programs. The company was founded by Calvin R. Stiller in December 2005 and is headquartered in Toronto, Canada.

Part of Blippmedia LLC, Pulse Medica provides medical surveillance services. The private company is based in Kinnelon, NJ. Pulse Medica was acquired by Blippmedia LLC on May 26, 2011.

XLV Diagnostics, Inc. operates as a medical imaging equipment company that develops, manufactures, and commercializes X-ray detectors for digital radiology machines used in early cancer detection and treatment applications. The firm also offers digital mammography machines. The company was founded in June 2011 and is headquartered in Thunder Bay, Canada.

Centre For Imaging Technology Commercialization medical technology manufacturer. The company is headquartered in London, Canada.

Zoic Capital LLC (Zoic Capital) is a venture capital firm founded in 2014 by Neal Mody and Eric Tan. The firm is headquartered in Seattle, Washington.

Turnstone Biologics, Inc. develops bio-therapeutics for the treatment of cancer. It develops Maraba oncolytic viral immunotherapy, a platform representing a disruptive approach in the treatment of cancer. The company was founded by David Stojdl, Brian D. Lichty and John C. Bell and is headquartered in Ottawa, Canada.

Xor Labs Toronto develops medical devices for organ transplantation and diseased organ treatment.

Amplify Capital Inc invests in companies located in the Canada. The fund targets companies operating in the fields of health, education and clean tech. It provides financing for seed and early stage capital requirements with investment size of less than $250000.

Cellaria Biosciences LLC engages in research and development of cancer cure products. The firm offers cancer research custom and stem cell services. The company is headquartered in Wakefield, MA.

UX Data Sciences Corp. operates as a medical technology and data science company. It developes UX-centric products and systems solutions for improving, tracking and monitoring medication adherence. The company was founded by German Kavoun and is headquartered in Ottawa, Canada.

Panakeia Technologies Ltd. is a company based in Cambridge, UK. The British company's mission is to make precision medicine accessible to patients and doctors worldwide, even in remote areas. Panakeia is revolutionizing biomarker testing by using AI to provide results in minutes instead of days or weeks, ultimately improving real-world treatment for patients. Additionally, the company runs an annual campaign to raise awareness about the impact of breast cancer. The company was founded in 2018 by Pahini Pandya and Pandu Raharja-Liu, with Pahini Pandya serving as the CEO since then.

Ultrasight is an Israeli company that aims to revolutionize cardiac sonography through the power of machine learning to enable more accurate and timely clinical decisions. The company is based in Rehovot, Israel. The company's Ultrasight AI guidance system helps bring the benefits of cardiac imaging to more healthcare professionals in new care settings, allowing patients access to ultrasound anywhere. Ultrasight has achieved CE marking for its real-time guidance software for cardiac ultrasound in the EU, and CA marking in the US. In 2020, Ultrasight won the TCT Innovation Competition, and in 2022, they won the Bristol Myers Squibb Improving Cardiovascular Disease Outcomes Challenge as the most "innovative cardiac technology." Additionally, the company was awarded a patent for its real-time guidance solution for ultrasound devices. The company was founded by Achi Ludomirsky, Itay Kezurer, Yaron Lipman. Davidi Vortman has been the CEO of the company since 2020.

Cross-Border Impact Ventures (Cross-Border Impact Ventures) is a venture capital firm founded in 2019 by Megan Dover. The firm is headquartered in Toronto, Canada.